| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |